# A Safety and Tolerability Study of ABT-126 in Elderly

> **NCT00867399** · PHASE1 · COMPLETED · sponsor: **Abbott** · enrollment: 30 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** ABT-126

## Key facts

- **NCT ID:** NCT00867399
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-05
- **Final completion:** —
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2010-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00867399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00867399, "A Safety and Tolerability Study of ABT-126 in Elderly". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00867399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*